IL47123A - Optically active 2-acylamino benzophenones and their preparation - Google Patents
Optically active 2-acylamino benzophenones and their preparationInfo
- Publication number
- IL47123A IL47123A IL47123A IL4712372A IL47123A IL 47123 A IL47123 A IL 47123A IL 47123 A IL47123 A IL 47123A IL 4712372 A IL4712372 A IL 4712372A IL 47123 A IL47123 A IL 47123A
- Authority
- IL
- Israel
- Prior art keywords
- general formula
- chlorobenzophenone
- amino
- boc
- cbo
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D243/00—Heterocyclic compounds containing seven-membered rings having two nitrogen atoms as the only ring hetero atoms
- C07D243/06—Heterocyclic compounds containing seven-membered rings having two nitrogen atoms as the only ring hetero atoms having the nitrogen atoms in positions 1 and 4
- C07D243/10—Heterocyclic compounds containing seven-membered rings having two nitrogen atoms as the only ring hetero atoms having the nitrogen atoms in positions 1 and 4 condensed with carbocyclic rings or ring systems
- C07D243/14—1,4-Benzodiazepines; Hydrogenated 1,4-benzodiazepines
- C07D243/16—1,4-Benzodiazepines; Hydrogenated 1,4-benzodiazepines substituted in position 5 by aryl radicals
- C07D243/18—1,4-Benzodiazepines; Hydrogenated 1,4-benzodiazepines substituted in position 5 by aryl radicals substituted in position 2 by nitrogen, oxygen or sulfur atoms
- C07D243/24—Oxygen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D243/00—Heterocyclic compounds containing seven-membered rings having two nitrogen atoms as the only ring hetero atoms
- C07D243/06—Heterocyclic compounds containing seven-membered rings having two nitrogen atoms as the only ring hetero atoms having the nitrogen atoms in positions 1 and 4
- C07D243/10—Heterocyclic compounds containing seven-membered rings having two nitrogen atoms as the only ring hetero atoms having the nitrogen atoms in positions 1 and 4 condensed with carbocyclic rings or ring systems
- C07D243/14—1,4-Benzodiazepines; Hydrogenated 1,4-benzodiazepines
- C07D243/16—1,4-Benzodiazepines; Hydrogenated 1,4-benzodiazepines substituted in position 5 by aryl radicals
- C07D243/18—1,4-Benzodiazepines; Hydrogenated 1,4-benzodiazepines substituted in position 5 by aryl radicals substituted in position 2 by nitrogen, oxygen or sulfur atoms
- C07D243/24—Oxygen atoms
- C07D243/28—Preparation including building-up the benzodiazepine skeleton from compounds containing no hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K1/00—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
- C07K1/006—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length of peptides containing derivatised side chain amino acids
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
- Y02P20/00—Technologies relating to chemical industry
- Y02P20/50—Improvements relating to the production of bulk chemicals
- Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Genetics & Genomics (AREA)
- Medicinal Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Biochemistry (AREA)
- Biophysics (AREA)
- General Health & Medical Sciences (AREA)
- Analytical Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Molecular Biology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Indole Compounds (AREA)
Abstract
1391081 Benzodiazepines CRC COMPAGNIA DI RICERCA CHIMICA SA 17 March 1972 [17 March 1971] 12567/72 Heading C2C 38-Compounds of the general formula (R<SP>1</SP> = H, halogen, NO 2 ; R<SP>2</SP> = H, C 1-4 alkyl; R<SP>3</SP> = C 1-4 alkyl, benzyl, substituted benzyl) are prepared by cyclizing a compound of the formula (A = protecting group) by removing the protecting group. The above compounds are sedatives and tranquillizers, and may be administered in the form of pharmaceutical preparations containing them in association with a carrier.
[GB1391081A]
Claims (1)
1. - 5 - 47123/3 1. Benzophenonee of general formula I which have in position 3 an asymetric carbon atom and wherein stands for a hydrogen or a halogen atom or for a nitro group; Eg stands for a hydrogen atom or for a lower alkyl radical with up to 4 carbon atoms and stands for lower alkyl with up to 4 carbon atoms, benzyl and p-hydroxy-benzyl radical and A stands for a protective group selected among H.HC1, H.HBr, tert.butoxycarbonyl (BOC), carbobenzoxy (CBO) and phthalimido. . (+)-2-N-(N·-BOC-alanyl)amino-5-chlorobenzophenones(S) 3. (+)-2-N-(N·-BOC-phenylalanyl)aiiiino-5-chlorobenzophenone( S) 4. (+)-2-N-( ·-BOC-tyrosyl)amino—5-chlorobenzophenone(S) 5· (+)-2-N-(N·-BOC-valyl)amino-5-chlorobenzophenone(S) 6. (+)-2-N-( '-CBO-alanyl)amino-5-chlorobenzophenone(S) 7. (+)-2-N-(N'-CBO-p enylalanyl)amino-5-chlorobenzophenone(8) 8. (+)-2-N-( '-CBO-tyrosyl)amino-5-chlorobenzophenone(S) 9. (+)-2-N-alejiylamino-5-chlorobenaophenonehydrobromide(S) - 6 - 47125/2 10. A process for the preparation of compounds of general formula I as defined in Claim 1 in which a compound of general formula II in which and It, have the same meaning as in general formula I is reacted with a compound of general formula III wherein and A have the same meaning as in general formula I. 11. A process according to Claim 10, wherein the reaction is performed in an inert solvent. 12. A process for the preparation of compounds of general formula I as defined in Claim 1,substantially as hereinbefore described with reference to the Examples. 15. Compounds of general formula I as defined in Claim 1, whenever prepared by the process according to any of claims 10 to 12.
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CH386871A CH554349A (en) | 1971-03-17 | 1971-03-17 | PROCESS FOR THE PREPARATION OF OPTICALLY ACTIVE 1,3-DIHYDRO-2H-1,4-BENZODIAZEPINE-2-ONES. |
Publications (1)
Publication Number | Publication Date |
---|---|
IL47123A true IL47123A (en) | 1976-09-30 |
Family
ID=4265209
Family Applications (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
IL38991A IL38991A (en) | 1971-03-17 | 1972-03-16 | Optically active 1,3-dihydro-5-phenyl-3-substituted 1,4-benzodiazepin-2-ones and their preparation |
IL47123A IL47123A (en) | 1971-03-17 | 1972-03-16 | Optically active 2-acylamino benzophenones and their preparation |
Family Applications Before (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
IL38991A IL38991A (en) | 1971-03-17 | 1972-03-16 | Optically active 1,3-dihydro-5-phenyl-3-substituted 1,4-benzodiazepin-2-ones and their preparation |
Country Status (16)
Country | Link |
---|---|
AT (1) | AT327909B (en) |
BE (1) | BE780892A (en) |
CA (1) | CA992079A (en) |
CH (1) | CH554349A (en) |
DE (1) | DE2212526A1 (en) |
ES (1) | ES400851A1 (en) |
FR (1) | FR2130342B1 (en) |
GB (2) | GB1391081A (en) |
HU (1) | HU165496B (en) |
IL (2) | IL38991A (en) |
NL (1) | NL7203536A (en) |
NO (1) | NO137896C (en) |
SE (1) | SE399887B (en) |
SU (1) | SU453842A3 (en) |
YU (1) | YU34882B (en) |
ZA (1) | ZA721845B (en) |
Families Citing this family (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CH602672A5 (en) * | 1974-06-28 | 1978-07-31 | Hoffmann La Roche | |
CH603655A5 (en) * | 1974-10-21 | 1978-08-31 | Hoffmann La Roche | |
AU6420700A (en) * | 1999-08-05 | 2001-03-05 | Prescient Neuropharma Inc. | Novel 1,4-benzodiazepine compounds and derivatives thereof |
-
1971
- 1971-03-17 CH CH386871A patent/CH554349A/en not_active IP Right Cessation
-
1972
- 1972-03-14 AT AT214972A patent/AT327909B/en not_active IP Right Cessation
- 1972-03-15 DE DE19722212526 patent/DE2212526A1/en active Pending
- 1972-03-16 IL IL38991A patent/IL38991A/en unknown
- 1972-03-16 FR FR7209250A patent/FR2130342B1/fr not_active Expired
- 1972-03-16 CA CA137,294A patent/CA992079A/en not_active Expired
- 1972-03-16 ES ES72400851A patent/ES400851A1/en not_active Expired
- 1972-03-16 IL IL47123A patent/IL47123A/en unknown
- 1972-03-16 NL NL7203536A patent/NL7203536A/xx unknown
- 1972-03-16 YU YU697/72A patent/YU34882B/en unknown
- 1972-03-16 NO NO853/72A patent/NO137896C/en unknown
- 1972-03-17 GB GB1256772A patent/GB1391081A/en not_active Expired
- 1972-03-17 SE SE7203457A patent/SE399887B/en unknown
- 1972-03-17 GB GB4955674A patent/GB1391082A/en not_active Expired
- 1972-03-17 BE BE780892A patent/BE780892A/en unknown
- 1972-03-17 SU SU1761120A patent/SU453842A3/ru active
- 1972-03-17 HU HUCA323A patent/HU165496B/hu unknown
- 1972-03-17 ZA ZA721845A patent/ZA721845B/en unknown
Also Published As
Publication number | Publication date |
---|---|
DE2212526A1 (en) | 1972-09-21 |
YU34882B (en) | 1980-04-30 |
BE780892A (en) | 1972-07-17 |
IL38991A (en) | 1976-09-30 |
YU69772A (en) | 1979-10-31 |
SE399887B (en) | 1978-03-06 |
ES400851A1 (en) | 1975-01-16 |
HU165496B (en) | 1974-09-28 |
GB1391081A (en) | 1975-04-16 |
FR2130342B1 (en) | 1977-01-14 |
CH554349A (en) | 1974-09-30 |
CA992079A (en) | 1976-06-29 |
FR2130342A1 (en) | 1972-11-03 |
NL7203536A (en) | 1972-09-19 |
IL38991A0 (en) | 1972-05-30 |
ZA721845B (en) | 1972-12-27 |
AT327909B (en) | 1976-02-25 |
SU453842A3 (en) | 1974-12-15 |
NO137896B (en) | 1978-02-06 |
ATA214972A (en) | 1975-05-15 |
NO137896C (en) | 1978-05-16 |
GB1391082A (en) | 1975-04-16 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
HUT49628A (en) | Process for producing new peptides and pharmaceutical compositions comprising same | |
ES483629A1 (en) | Novel naphtyridine derivatives and pharmaceutical compositions containing them. | |
KR930006027A (en) | 2-substituted indan-2-mercaptoacetylamide derivatives useful as inhibitors of enkephalinase and angiotensin converting enzyme (ACE) | |
GB1435139A (en) | Thiazole derivatives | |
ES488656A1 (en) | N-substituted 2-cyanaziridines, methods for their preparation and medicaments containing them, correspondingly substituted aziridine-2-carbonamides and their preparation. | |
KR960703411A (en) | Method for preparing 1-deamino-8-D-arginine vasopressin | |
GB1129116A (en) | Lactam derivatives | |
IL47123A (en) | Optically active 2-acylamino benzophenones and their preparation | |
GB1514776A (en) | Compositions containing oxamic acid derivatives | |
GB1468114A (en) | Triazino 4,3-a 1,4-benzodiazepin-2 1h-ones and their pharmaceuti cal compositions | |
ES8606880A1 (en) | Novel peptides and process for preparing the same and pharmaceutical composition. | |
GB1374562A (en) | Process for the production of insulin derivatives and their medicinal use | |
GB1505543A (en) | Benzodiazepine derivatives and a process for the preparation thereof | |
IL42944A (en) | Basically substituted benzene-1,3-disulfonamides and process for their manufacture | |
GB1451902A (en) | Bromo dihydrolysergic acid | |
JPS5645449A (en) | Novel peptide, its pharmaceutically acceptable salt and preparation of the same | |
GB1498083A (en) | Pharmaceutical preparations | |
GB1173562A (en) | Chloramphenicol Ester Salts, the Preparation therof and Compositions Containing them | |
KR850002287A (en) | Method for preparing insulin derivatives | |
GB1227905A (en) | ||
GB1509445A (en) | Benzodiazepine derivatives and a process for the preparation thereof | |
GB1470748A (en) | 6-2-pyridyl-4h-s-triazolo-4,3-a-1,4-benzodiazepines | |
GB1444529A (en) | Benzodiazepine derivatives | |
GB1309868A (en) | Benzodiazepine derivativers and a aprocess for the manufacture thereof | |
GB974989A (en) | Hydroxy-benzenesulphonyl-ureas and preparations containing them |